| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.29▼ | 2.27▼ | 2.28▼ | 2.40▼ | 2.21▲ |
| MA10 | 2.28▼ | 2.29▼ | 2.36▼ | 2.51▼ | 1.92▲ |
| MA20 | 2.28▼ | 2.39▼ | 2.48▼ | 2.25▲ | 1.67▲ |
| MA50 | 2.29▼ | 2.49▼ | 2.54▼ | 1.93▲ | 1.67▲ |
| MA100 | 2.37▼ | 2.57▼ | 2.39▼ | 1.67▲ | 1.57▲ |
| MA200 | 2.48▼ | 2.34▼ | 2.32▼ | 1.61▲ | 4.17▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.011▼ | -0.028▼ | -0.021▼ | 0.109▲ |
| RSI | 38.639▼ | 38.104▼ | 35.013▼ | 50.471▲ | 57.932▲ |
| STOCH | 63.095 | 14.675▼ | 10.128▼ | 39.480 | 53.342 |
| WILL %R | -100.000▼ | -98.276▼ | -98.876▼ | -61.691 | -49.789 |
| CCI | -70.510 | -69.912 | -92.512 | -10.902 | 91.477 |
|
Friday, November 06, 2026 03:16 AM
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, November 05, 2026 07:05 PM
Pacific Biosciences posted mixed Q3 results, cut 2026 sales guidance, and continues heavy cash burn. Read here for more details on PACB stock.
|
|
Wednesday, November 04, 2026 09:37 PM
Genomics company Pacific Biosciences of California (NASDAQ:PACB) announced in Q3 2026, with sales up 5.5% year on year to $40.56 million. Its non-GAAP loss of $0.11 per share was 16.1% above analysts’ ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 2.43 | 2.54 | 2.24 | 2.26 | 9,533,500 |
| 05/11/26 | 2.24 | 2.69 | 2.23 | 2.43 | 20,047,113 |
| 04/11/26 | 2.53 | 2.70 | 2.48 | 2.55 | 20,904,630 |
| 03/11/26 | 2.41 | 2.5799 | 2.4001 | 2.44 | 6,247,151 |
| 02/11/26 | 2.68 | 2.7194 | 2.31 | 2.345 | 9,099,749 |
| 30/10/26 | 2.75 | 2.82 | 2.4101 | 2.605 | 13,723,340 |
| 29/10/26 | 2.775 | 2.96 | 2.74 | 2.90 | 11,841,397 |
| 28/10/26 | 2.45 | 3.065 | 2.44 | 2.83 | 34,911,656 |
| 27/10/26 | 2.26 | 2.525 | 2.23 | 2.45 | 18,665,393 |
| 26/10/26 | 2.12 | 2.305 | 2.08 | 2.25 | 9,561,160 |
|
|
||||
|
|
||||
|
|